SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
XTNT

Xtant Medical Holdings, Inc. (New York Stock Exchange Arca:XTNT)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.21-$0.01 (-2.82%)
 
Market cap
$29.5M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 1, 2010
Market Cap$29.49M-66.2%
Revenue (ttm)$100.56M-24.4%
Net Income-$16.01M-1014.2%
EPS-$0.12-1221.4%
Shares Out140.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume257,127
Open$0.23
Previous Close$0.22
Day's Range$0.20 - $0.23
52-Week Range$0.17 - $0.84
Betan/a
AnalystsBuy
Price Target$1.00(+376.19%)
Earnings DateMar 9, 2027
-2.82% (1D)
No price history available.

About XTNT

Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive product portfolio is categorized into several key areas: 1. Biomaterial Offerings: This category includes products like OsteoSponge, which provides a natural structural support for cellular growth and introduces vital bone-forming proteins to aid the healing process. OsteoSponge SC is specifically designed to repair bone defects in the subchondral area of joints. Other items are OsteoSelect DBM Putty, fostering osteoinductive bone regeneration, and OsteoSelect PLUS DBM Putty, which functions as a bone void filler and graft substitute for procedures involving the pelvis, extremities, and posterolateral spine. Additionally, the line features OsteoFactor, containing diverse proteins and peptides that facilitate bone formation and remodeling, along with OsteoWrap and OsteoVive Plus, a cellular bone matrix enriched with growth factors. 2. Allograft Technologies: Under the 3Demin brand, Xtant Medical provides a range of allografts (human bone grafts) engineered to maximize both osteoconductivity and osteoinductive capabilities. This includes specialized sports allografts used for repairing anterior and posterior cruciate ligaments, ACL reconstruction, and meniscal repairs. They also offer milled spinal allografts, where cortical bone is precisely shaped to specific dimensions, as well as traditional allografts applicable across numerous medical disciplines such such as orthopedics, neurology, podiatry, oral/maxillofacial surgery, genitourinary, and plastic/reconstructive surgery. 3. Spinal Fixation and Fusion Systems: The company furnishes a variety of sophisticated spinal devices. These include the Certex spinal fixation system, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, the Xpress minimally invasive pedicle screw system, and Fortex Pedicle screw systems. Further systems encompass Calix, for use in cervical and thoracolumbar regions, the Axle-X interspinous fusion system, Irix-C for cervical integrated fusion, and the Irix-A Lumbar integrated fusion system. The company underwent a name change in July 2015, transitioning from its former identity as Bacterin International Holdings, Inc. to Xtant Medical Holdings, Inc.

Address
664 Cruiser Lane, Belgrade, MT, 59714, US
Market Cap
29 million
Employees
151
Industrial Classification
Medical - Devices
Financial Health Score
Fair
From XTNT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.82%
5 Days
-19.23%
1 Month
-29.05%
6 Months
-55.33%
1 Year
-66.18%

$XTNT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in XTNT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by XTNT's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

XTNT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

XTNT Revenue by Segment or Geography

XTNT's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New XTNT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to XTNT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in XTNT

VTIVanguard Morningstar Total Stock Market ETF$331.05K
VXFVanguard Extended Market ETF$144.40K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$10.00K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from XTNT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
85
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.02%

Weight is the stock’s share of each fund’s holdings.